Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Generate Biomedicines, Inc. - Common Stock (NQ:GENB)

11.91 -1.15 (-8.77%)
Delayed Quote Updated: 1:17 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Generate Biomedicines, Inc. - Common Stock

News headline image
AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test
From Biotech Insider
Via GlobeNewswire
News headline image
Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
From Generate Biomedicines, Inc.
Via GlobeNewswire
News headline image
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
From Generate Biomedicines, Inc.
Via GlobeNewswire
News headline image
Generate Biomedicines Inc. to Participate in September Investor Conferences
From Generate Biomedicines, Inc.
Via GlobeNewswire
News headline image
Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update
From Generate Biomedicines, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.